Methicillin-resistant Staphybcoccus aureus: An update for the dermatologist, part 4: Additional therapeutic considerations

Cutis

Volumn 81, Issue 4, 2008, Pages 343-347

  Kil, Erin H ^a   Heymann, Warren R ^b   Weinberg, Jeffrey M ^a,c,d,e  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN;

ANTISEPSIS; COMMUNICABLE DISEASE; DRUG EFFECT; HUMAN; METHODOLOGY; MICROBIOLOGY; NOSE CAVITY; PENICILLIN RESISTANCE; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTISEPSIS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; METHICILLIN RESISTANCE; NASAL CAVITY; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 43249091232     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)